CN Patent

CN114929279A — Shp2抑制剂给药和治疗癌症的方法

Assigned to Ruixin Pharmaceutical Co · Expires 2022-08-19 · 4y expired

What this patent protects

公开了SHP2抑制剂组合物和使用间歇性给药时间表治疗疾病或障碍的方法。

USPTO Abstract

公开了SHP2抑制剂组合物和使用间歇性给药时间表治疗疾病或障碍的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN114929279A
Jurisdiction
CN
Classification
—
Expires
2022-08-19
Drug substance claim
No
Drug product claim
No
Assignee
Ruixin Pharmaceutical Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.